SSRI/SNRI -induced Hyponatremia: A Case Series of 26 Patients in a Single Institution from 2018 to 2020
- 13 March 2023
- journal article
- research article
- Published by Springer Nature in Psychiatric Quarterly
- Vol. 94 (2) , 113-125
Abstract
Antidepressant medications are widely used by patients with depression or a depressive disorder. In spite of a generally favorable safety profile of selective serotonin reuptake inhibitors or serotonin - norepinephrine reuptake inhibitors (SSRI/SNRI), several cases of a possible connection between SSRI/SNRI and hyponatremia have been reported. To describe the clinical characteristics of patients with hyponatremia after SSRI/SNRI exposure, and to examine the association between SSRI/SNRI exposure and the presence of hyponatremia in a Chinese population. A retrospective single-center case series study. We performed a retrospective evaluation of inpatients with SSRI/SNRI-induced hyponatremia from a single institution in China between 2018 and 2020. Clinical data were obtained through review of medical records. Patients who met the initial inclusion criteria but did not develop hyponatremia acted as controls. The study was approved by the Clinical Research Ethics Board of Beijing Hospital (Beijing, P.R. China). We identified 26 patients with SSRI/SNRI-induced hyponatremia. The incidence rate of hyponatremia was 1.34% (26/1937) in the study population. The mean age at diagnosis was 72.58 (±12.84) years, with a male: female ratio of 1:1.42. The duration between SSRI/SNRI exposure and the onset of hyponatremia was 7.65 (±4.88) days. The minimum serum sodium level was 2328.23 (±107.25) mg/dL in the study group. Seventeen patients (65.38%) received sodium supplements. Four patients (15.38%) switched to another antidepressant. Fifteen patients (57.69%) recovered by the time of discharge. There were significant differences in serum potassium, serum magnesium and serum creatinine level between the two groups (p < 0.05). The rate of use of sertraline was significantly higher in the study group compared with the control group (p < 0.05). This pattern was not found in other SSRI/SNRI (p > 0.05). The results of our study show that SSRI/SNRI exposure, in addition to hyponatremia, may also affect the level of serum potassium, serum magnesium and serum creatinine. A history of hyponatremia and exposure to SSRI/SNRI may be potential risk factors for the development of hyponatremia. Future prospective studies are needed to validate these findings.Keywords
Funding Information
- National Key R&D Program of China (2020YFC2008305)
This publication has 26 references indexed in Scilit:
- Antidepressants and the Risk of Hyponatremia: A Class-by-Class Review of LiteraturePsychosomatics, 2014
- Significance of hypo- and hypernatremia in chronic kidney diseaseNephrology Dialysis Transplantation, 2012
- Hyponatremia, Hypernatremia, and Mortality in Patients With Chronic Kidney Disease With and Without Congestive Heart FailureCirculation, 2012
- A case of non-SIADH-induced hyponatremia in depression after treatment with reboxetineThe World Journal of Biological Psychiatry, 2009
- Hyponatremia as a complication of selective serotonin reuptake inhibitorsJournal of the American Academy of Nurse Practitioners, 2008
- Hyponatremia Associated with Selective Serotonin-Reuptake Inhibitors in Older AdultsAnnals of Pharmacotherapy, 2006
- Citalopram Therapy as a Risk Factor for Symptomatic Hyponatremia Caused by the Syndrome of Inappropriate Secretion of Antidiuretic Hormone (SIADH)Pharmacopsychiatry, 2005
- Delayed Recurrent SIADH Associated with SSRIsAnnals of Pharmacotherapy, 2002
- Incidence and risk factors for hyponatraemia following treatment with fluoxetine or paroxetine in elderly peopleBritish Journal of Clinical Pharmacology, 1999
- Mapping study of noradrenergic stimulation of vasopressin releaseExperimental Neurology, 1990